UroGen Pharma (NASDAQ:URGN) Shares Gap Up on Analyst Upgrade
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report)’s stock price gapped up before the market opened on Friday after Scotiabank raised their price target on the stock from $23.00 to $47.00. The stock had previously closed at $11.08, but opened at $11.96. Scotiabank currently has a sector outperform rating on the stock. UroGen Pharma shares […]
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report)’s stock price gapped up before the market opened on Friday after Scotiabank raised their price target on the stock from $23.00 to $47.00. The stock had previously closed at $11.08, but opened at $11.96. Scotiabank currently has a sector outperform rating on the stock. UroGen Pharma shares […]
